Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Trimeris Expands Fuzeon Distribution; Reimbursement Remains Challenge

Executive Summary

Roche and Trimeris are expanding distribution of the HIV therapy Fuzeon into retail channels through StatScript, the companies said during an analyst call Sept. 25
Advertisement

Related Content

Gilead Leads Biotech Rebound In 2003: Product Stories Play Well
Gilead Leads Biotech Rebound In 2003: Product Stories Play Well
Rx Access PR Effort Needs Hiatus, Pfizer Says; Roche Wants To Get Personal
Rx Access PR Effort Needs Hiatus, Pfizer Says; Roche Wants To Get Personal
HIV Market: Reyataz Races To 10% Market Share, Fuzeon Building Steadily
Roche Fuzeon Approval Presents Challenges Of Reimbursement, Supply
Advertisement
UsernamePublicRestriction

Register

PS042591

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel